GemPharmatech Co (SHSE:688046) Change In Payables And Accrued Expense : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co Change In Payables And Accrued Expense?

GemPharmatech Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means GemPharmatech Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

GemPharmatech Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0.0 Mil. It means GemPharmatech Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

GemPharmatech Co Change In Payables And Accrued Expense Historical Data

The historical data trend for GemPharmatech Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co Change In Payables And Accrued Expense Chart

GemPharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

GemPharmatech Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial												-	-	-	-	-

GemPharmatech Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

GemPharmatech Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

GemPharmatech Co (SHSE:688046) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032

Website

https://www.gempharmatech.us

GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co (SHSE:688046) Headlines

No Headlines